- Home
- KNRX vs POM Comparison
KNRX vs POM Comparison
Compare KNRX & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNRX | POM |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | Singapore | China |
| Employees | N/A | 165 |
| Industry | Computer Software: Programming Data Processing | Other Specialty Stores |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1M | 11.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KNRX | POM |
|---|---|---|
| Price | $0.38 | $0.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 99.0K | 98.4K |
| Earning Date | 06-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.06 |
| 52 Week High | $3.45 | $6.43 |
Technical Indicators
Market Signals| Indicator | KNRX | POM |
|---|---|---|
| Relative Strength Index (RSI) | 37.70 | 47.49 |
| Support Level | $0.34 | $0.17 |
| Resistance Level | $0.49 | $1.78 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 10.18 | 50.13 |
Price Performance
Historical ComparisonAbout KNRX KNOREX LTD. Class A Ordinary Shares
Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. The company's product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.